Central nervous system
|
Headache
|
Mao, Ling et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology vol. 77,6 (2020): 683-690. doi:
10.1001/jamaneurol.2020.1127
|
214
|
28
|
13.1%
|
|
Dizziness
|
|
|
36
|
16.8%
|
|
Seizures
|
|
|
2
|
2%
|
|
Cerebral haemorrhage
|
Craen, Alexandra et al. “Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.” Cureus vol. 12,4 e7846. 27 Apr. 2020, doi:
10.7759/cureus.7846
|
Case report
|
Case report
|
|
|
Acute cerebrovascular disease
|
Mao, Ling et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology vol. 77,6 (2020): 683-690. doi:
10.1001/jamaneurol.2020.1127
|
214
|
6
|
2.8 %
|
|
Ischemic stroke
|
Tan, Y. K., Goh, C., Leow, A., Tambyah, P. A., Ang, A., Yap, E. S., Tu, T. M., Sharma, V. K., Yeo, L., Chan, B., & Tan, B. (2020). COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. Journal of thrombosis and thrombolysis, 50(3), 587–595. doi:
10.1007/s11239-020-02228-y
|
362
|
9
|
2.5%
|
|
Insomnia
|
Kokou-Kpolou, Cyrille Kossigan et al. “Insomnia during COVID-19 pandemic and lockdown: Prevalence, severity, and associated risk factors in French population.” Psychiatry research vol. 290 (2020): 113128. doi:
10.1016/j.psychres.2020.113128
|
556
|
|
18.2%
|
|
|
Huang, Yeen, and Ning Zhao. “Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey.” Psychiatry research vol. 288 (2020): 112954. doi:
10.1016/j.psychres.2020.112954
|
7236
|
1317
|
18.2%
|
|
cerebral venous thrombosis
|
Garaci, Francesco et al. “Venous cerebral thrombosis in COVID-19 patient.” Journal of the neurological sciences vol. 414 (2020): 116871. doi:
10.1016/j.jns.2020.116871
|
Case report
|
|
|
|
Ataxia
|
Mao, Ling et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology vol. 77,6 (2020): 683-690. doi:
10.1001/jamaneurol.2020.1127
|
214
|
1
|
0.5%
|
Peripheral neurological manifestation
|
Gillian bare syndrome
|
Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. 2020 Jun;76:233-235. doi: 10.1016/j.jocn.2020.04.062
Epub 2020 Apr 15. PMID: 32312628; PMCID: PMC7158817
|
Case report
|
|
|
|
ophthalmoplegia and polyneuritis
|
Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020; 94(22):959–69
|
Review
|
|
|
|
|
Mao, Ling et al. “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology vol. 77,6 (2020): 683-690. doi:
10.1001/jamaneurol.2020.1127
|
214
|
Loss Taste in 12 patients
|
5.6%
|
|
|
|
|
Loss Smell in 11 patients
|
5.1%
|
|
|
|
|
Vision Defect in 3 patients
|
1.4%
|
|
|
|
|
Nerve pain in 5 patients
|
2.3%
|
|
|
|
|
Skeletal muscle injury in 23 patients
|
10.7%
|
|
Acute myelitis and Hypotonia
|
AlKetbi, Reem et al. “Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings.” Radiology case reports vol. 15,9 1591-1595. 6 Jun. 2020, doi:
10.1016/j.radcr.2020.06.001
|
|
Case report
|
|